Key result
A maximum cardiac troponin I level >0.545 ng/mL within 7 days after liver transplantation was independently associated with 28-day mortality (OR 0.424).
Why the study?
The change pattern, clinical significance, and association with 28-day mortality of perioperative cardiac troponin I in adults undergoing liver transplantation were not well defined.
Does elevated perioperative cardiac troponin I predict 28-day mortality in adult patients undergoing elective orthotopic liver transplantation?
Cohort (n=414)
No
Does elevated perioperative cardiac troponin I predict 28-day mortality in adult patients undergoing elective orthotopic liver transplantation?
Odds Ratio: 0.424 (95% CI 0.214–0.842)
p-value: p=0.014
A postoperative cTnI elevation >0.545 ng/mL is an independent predictor of 28-day mortality in patients undergoing liver transplantation, highlighting its utility in perioperative risk stratification.
Objective: To examine the change rule and clinical significance of cardiac troponin I (cTnI) in the perioperative period of liver transplantation in adults, as well as its association with 28-day mortality. Methods: This was a retrospective cohort study: patients who underwent elective orthotopic liver transplantation (OLT) in Beijing Chao-Yang Hospital between June 2015 and June 2020 were selected, and plasma cTnI values were collected through the electronic medical record system within 7 days after surgery. Furthermore, the baseline clinical data of these patients were collected, and the change curve of cTnI values following liver transplantation was plotted. Using univariate and multivariate logistic regression models, the relationship between the level of postoperative cTnI and short-term mortality was investigated. The primary study endpoint was mortality within 28 days after surgery. Results: We included 414 patients who had undergone liver transplantation in this study, 48 of whom died within 28 days after surgery. cTnI, a specific marker of myocardial injury, could predict that the postoperative cardiovascular complications were higher in the death group and significantly affect the short-term prognosis of patients; however, its prognostic cut-off value was approximately 0.545 ng/mL (13×URL), indicating that a minor elevation of cTnI after liver transplantation did not significantly affect the prognosis. Moreover, a comparison of the baseline data and postoperative ICU management scores of the two groups revealed that diabetes, maximum value of cTnI >0.545 ng/mL within 7 days, and the need for postoperative renal replacement therapy (RRT) were independent prognostic factors of death within 28 days after liver transplantation. Conclusion: Within 7 days after surgery, an increase in cTnI to the maximum value of 0.545 ng/mL (13×URL) could have a significant impact on the short-term prognosis of patients. Diabetes and postoperative RRT were two independent prognostic factors for liver transplantation perioperative mortality.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted a cohort in Liver transplantation (n=414). Maximum cardiac troponin I >0.545 ng/mL within 7 days vs. Maximum cardiac troponin I ≤0.545 ng/mL was evaluated on Mortality within 28 days after surgery (OR 0.424, 95% CI 0.214-0.842, p=0.014). A maximum cardiac troponin I level >0.545 ng/mL within 7 days after liver transplantation was independently associated with 28-day mortality (OR 0.424).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: